Xenex Disinfection Services Inc. — Cyborg Score 7/10
Strong
Healthcare Equipment & Disinfection Technology
Strategic Profile
Xenex's pulsed, high energy UV light technology is uniquely lethal to microorganisms – producing peaks 4300x more intense than a mercury lamp. The company works with 900+ prominent facilities including over 130 government facilities utilizing Xenex programs for pathogen deactivation.
Cyborg Score Rationale
Xenex demonstrates strong product-market fit with established adoption across 900+ healthcare facilities and differentiated UV disinfection technology. The company has experienced leadership with successful startup track records and solid investor backing, though limited public financial disclosure and private status constrain full visibility.
Top Insights
Founders Mark Stibich and Julie Stachowiak are Johns Hopkins epidemiologists who built the company to provide healthcare facilities a more effective approach to prevent pathogen transmission driven by scientific evidence
CEO Morris Miller co-founded and funded Xenex; he previously co-founded Rackspace Managed Hosting, which was brought private by Apollo for $4.3 billion
Xenex has 16 investors including Battery Ventures, RK Ventures, and Targeted Technology Fund II
The company has 51-200 employees as of recent data
Named Competitors
TOMI Environmental Solutions — Hydrogen peroxide vapor disinfection systems
American BioScience Inc. — Hospital disinfection and sterilization solutions